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Analysis of complete capsid sequences of the emerging 
norovirus GII.17 Kawasaki 308 from 13 countries demon-
strated that they originated from a single haplotype since 
the initial emergence in China in late 2014. Global spread 
of a sublineage SL2 was identified. A new sublineage SL3 
emerged in China in 2016.
Norovirus infections are a leading cause of acute gas-troenteritis worldwide in persons of all age groups. 
Despite the broad genetic diversity, norovirus GII.4 has 
predominated during the past 20 years (1). During winter 
2014–15, a new norovirus GII genotype 17 variant, known 
as Kawasaki 308–like 2014 (GII.17 Kawasaki), emerged 
and became the predominant genotype in Hong Kong, Chi-
na (2), several major cities of mainland China (3,4), and Ja-
pan (5). This variant also was detected sporadically outside 
of Asia in countries such as Italy, Romania, and the United 
States (6–8). This new GII.17 Kawasaki variant is distinct 
from other GII.17 strains, including the co-circulating Ka-
wasaki 323–like strains; it has 2 characteristic amino acid 
insertions in the most surface-exposed antigenic region of 
the major capsid viral protein 1 (VP1) (2). These changes 
have the potential to alter the antigenic properties or the vi-
rus–host cell binding preference, raising concern about the 
global spread of this variant and its replacement of GII.4 
variants (9). To study the phylodynamic transmission pat-
tern of norovirus GII.17 Kawasaki, we analyzed full-length 
VP1 nucleotide sequences collected worldwide during late 
2014 through early 2016.
The Study
We chose the region VP1 to analyze because it contained the 
most hypervariable protruding domain 2 across the norovi-
rus genome and represented most sequences deposited in the 
public domain. The entire dataset comprised 254 complete 
VP1 sequences from 13 countries, and all were obtained 
from samples collected during September 2014–March 2016 
(Table). Among them, 129 sequences from 10 countries were 
determined for this study (online Technical Appendix, https://
wwwnc.cdc.gov/EID/article/23/8/16-1138-Techapp1.pdf), 
and the remaining 125 sequences were retrieved from Gen-
Bank. These sequences were collected from diverse settings, 
including outbreaks in healthcare facilities and food-serving 
sites, sporadic community cases, and hospitalized patients 
(online Technical Appendix Table 1).
GII.17 Kawasaki viruses were found in 13 countries 
across 4 continents: Canada, China, Germany, Hungary, It-
aly, Japan, the Netherlands, New Zealand, Russia, Slovenia, 
South Korea, Thailand, and the United States. Australia and 
South Africa reported no GII.17 Kawasaki as of mid-2015 
and early 2016, respectively. Maximum-likelihood phylo-
genetic inference showed different genetic clusters within 
GII.17 Kawasaki, indicating rapid genetic diversification 
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of viral population during spread (Figure 1; online Techni-
cal Appendix Figure). Sequences from the same continent 
scattered into different genetic clusters, inferring multiple 
introduction and frequent transmission events. To investi-
gate the virus transmission pattern, we constructed a medi-
an-joining haplotype network based on complete VP1 nu-
cleotide sequences (online Technical Appendix). Overall, 
the 254 VP1 sequences comprised 207 different haplotypes 
(Figure 2). We identified a highly connected basal haplo-
type (Figure 2) that consisted of 8 identical VP1 sequences 
collected in the initial phase of the epidemic during No-
vember 2014–March 2015 from 6 cities mostly in Asia (2 
from Hong Kong; 1 from Shanghai, China; 1 from Guang-
zhou, China; 1 from Taiwan; 2 from South Korea; and 1 
from Russia). The same basal haplotype was concluded 
using integer neighbor-joining and tight span walker net-
work models. The central node might represent a compe-
tent virus haplotype capable of replicating and spreading 
efficiently among humans and from which nearly all hap-
lotypes originated. We found only 2 nucleotide differences 
without amino acid change between the basal haplotype 
and the first case-patient with GII.17 Kawasaki virus in this 
study (NS-405; collected in September 2014 from Hong 
Kong) (Figure 2, black arrow). We determined complete 
genomes that comprised the basal haplotype for this study 
for the 2 Hong Kong strains and downloaded data for the 
2 South Korea strains. These viruses had 4 unique amino 
acid substitutions distinct from NS-405: 2 in the nonstruc-
tural polyprotein (A187D in N terminal protein and N739S 
in protease) and 2 in VP2 (K58R and A89S; outside of 
the VP1-interacting domain) (online Technical Appendix 
Table 2). Substitution in the protease might mediate chang-
es in the cleavage efficiency of the polyprotein in norovi-
rus replication (10). Although we noted no substitutions in 
the RNA-dependent RNA polymerase, N terminal protein 
and VP2 were previously implicated in modulating poly-
merase activity, virus tropism, and persistence (11,12). The 
4 non-VP1 residues may affect viral fitness of the emergent 
GII.17 Kawasaki in humans; however, functional charac-
terization is required (13).
We identified 3 important sublineages by topology 
(Figure 2). Viruses belonging to sublineage SL1 (Figure 
2, blue shading) clustered closest to the first GII.17 Ka-
wasaki isolate in this study. SL1 included strains from 6 
countries outside of China across 3 continents: Thailand 
(collected in October 2014), United States (November 
2014), Italy and the Netherlands (February 2015), Slove-
nia (August 2015), and Canada (December 2015–Janu-
ary 2016). The global spread of GII.17 Kawasaki viruses 
within a few months after the initial emergence in China in 
late 2014 highlights rapid transmissibility of these viruses. 
Despite the molecular evidence of early global presence 
of SL1, the apparent limited circulation of this sublineage 
is intriguing. SL1 was the only sublineage not originat-
ing from the basal haplotype but directly from the earliest 
NS-405. Sequence analysis of the other 2 SL1 complete 
genomes available, collected from the United States (Hu/
GII.17/Gaithersburg/2014/U.S.; GenBank accession no. 
KR083017) and Taiwan (Hu/GII.17/CGMH70/2015/TW; 
GenBank accession no. KR154231), found none of the 4 
non-VP1 substitutions observed in the basal haplotype. In 
this dataset, viruses belonging to sublineage SL2 had the 
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Table. Number of complete viral protein 1 nucleotide sequences of norovirus genogroup II genotype 17 Kawasaki analyzed from 
September 2014 to March 2016, grouped by country, source of sequence, and time of collection* 
Region and country 
Source of sequence 
 
Year of collection, quarter 
Total 
2014 
 
2015 
 
2016 
GenBank This study Q3 Q4 Q1 Q2 Q3 Q4 Q1 
Asia               
 China              
  Hong Kong 81 45  1 26  67 12 
 
2  18 126 
  Shanghai 3 8  
 
2  1 1 
 
2  5 11 
  Other cities 31 
 
 
 
3  28 
   
 
 
31 
 Other countries              
  Japan 2 13  
  
 8 
 
2 
 
 5 15 
  South Korea 5 
 
 
 
2  2 1 
  
 
 
5 
  Thailand 
 
7  
 
1  
  
1 5  
 
7 
Oceania: New Zealand  6       2 2  2 6 
Europe              
 Germany 
 
5  
  
 
 
1 
 
3  1 5 
 Hungary 1 
 
 
  
 
   
1  
 
1 
 Italy 1 
 
 
  
 1 
   
 
 
1 
 The Netherlands 
 
5  
  
 1 2 
 
2  
 
5 
 Russia 
 
25  
  
 1 2 8 12  2 25 
 Slovenia 
 
4  
  
 
 
1 2 
 
 1 4 
North America              
 Canada 
 
6  
  
 
  
1 2  3 6 
 United States 1 5  
 
1  
 
1 2 
 
 2 6 
Total 125 129  1 35  109 21 18 31  39 254 
*Blank cells indicate 0. 
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Figure 1. Maximum-likelihood phylogenetic inference of complete viral protein 1 nucleotide sequences of norovirus GII.17 Kawasaki. 
The tree was constructed using MEGA6 (http://www.megasoftware.net) (online Technical Appendix, https://wwwnc.cdc.gov/EID/
article/23/8/16-1138-Techapp1.pdf). The red asterisk denotes the reference sequence of GII.17 Kawasaki virus (Hu/GII/JP/2015/
GII.P17_GII.17/Kawasaki308; GenBank accession no. LC037415). The tree is rooted to genotype GII.21 (not shown for clarity). 
Bootstrap values >70 (percentage) are shown at nodes. Sublineages SL1 to SL3 are defined by the topology of haplotype network 
shown in Figure 2. Branches are colored by the continent of sequence origin. The tree is drawn in scale; scale bar indicates 
nucleotide substitutions per site. 
Norovirus GII.17 Kawasaki 308
most cases and widest geographic breadth (Figure 2, pink 
shading). SL2 was detected in 6 countries outside of China 
across 3 continents (Germany, Japan, New Zealand, Rus-
sia, Slovenia, and Thailand) and most of the non-China 
sequences from 2014–15 (36%) and 2015–16 (41%) sea-
sons belonged to this sublineage (Figure 2, inset). The 
most successful SL2 might have an advantage to global 
spread, although we cannot rule out sampling bias. Dur-
ing the 2015–16 season, SL2 continued to circulate over 
a wide geographic area, although none of the sequences 
from China belonged to this sublineage. Instead, sublin-
eage SL3, first detected in January 2015 as a minority (7%) 
in China in the 2014–15 season, became the predominant 
(63%) circulating GII.17 Kawasaki virus in both southern 
(Hong Kong) and eastern (Shanghai) parts of China during 
2015–16 among sequences analyzed (Figure 2, green shad-
ing and inset). No sequences from other countries clustered 
into SL3. This emerging sublineage highlights that GII.17 
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Figure 2. Median-joining haplotype network of 254 complete viral protein 1 nucleotide sequences of norovirus GII.17 Kawasaki. A) Each 
vertex represents a unique sampled haplotype. Internal black nodes are unsampled intermediate hypothetical haplotypes. Black arrow 
denotes the first case of norovirus GII.17 Kawasaki in this study (NS-405; collected in September 2014 from Hong Kong). Blue arrow 
denotes a highly connected basal haplotype from which nearly all haplotypes originated. Vertices are colored by country of collection. 
Blue shading indicates a sublineage (SL1) genetically closest to the first case of GII.17 Kawasaki virus in this study. Pink shading 
indicates a sublineage (SL2) with global spread. Green shading indicates an emergent sublineage (SL3) in China in 2016. Vertex size is 
proportional to the number of sampled sequences sharing the same haplotype. Length of edge is not drawn to scale. Each hatch mark 
indicates 1 nt difference between connecting haplotypes/nodes. Red triangles represent reference strains of corresponding sublineage 
(online Technical Appendix Table 1, https://wwwnc.cdc.gov/EID/article/23/8/16-1138-Techapp1.pdf). The asterisk denotes the reference 
sequence of GII.17 Kawasaki virus (Hu/GII/JP/2015/GII.P17_GII.17/Kawasaki308; GenBank accession no. LC037415). Bar charts 
show the number (gray bars) and percentage (black squares) of cases of sublineages SL2 (B) and SL3 (C) by country in the seasons of 
2014–15 (September 2014–June 2015) and 2015–16 (July 2015–March 2016).
DISPATCHES
Kawasaki viruses were still circulating and, more impor-
tant, rapidly evolving in various regions of China. Robust-
ness of sublineage topology was confirmed in the phyloge-
netic tree (Figure 1).
Conclusions
We determined the complete VP1 sequences of 129 GII.17 
Kawasaki strains from 10 countries. Our analyses suggest 
that the new GII.17 Kawasaki originated from a single hap-
lotype from which rapid genetic diversification into mul-
tiple sublineages occurred during global spread after the 
initial emergence in China in late 2014. Norovirus diversi-
fication into sublineages provides a preepidemic virus pool 
from which new pandemic GII.4 variants emerged (14). 
Although our study is limited by its focus on VP1 sequence 
analysis and not on virus genomes, it nevertheless is a good 
demonstration that a global network of norovirus laborato-
ries sharing virus sequence information can delineate virus 
transmission pattern upon spread.
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